Scott Harkonen

559 total citations
11 papers, 420 citations indexed

About

Scott Harkonen is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Scott Harkonen has authored 11 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Scott Harkonen's work include HIV/AIDS drug development and treatment (3 papers), Neurological and metabolic disorders (2 papers) and Transgenic Plants and Applications (2 papers). Scott Harkonen is often cited by papers focused on HIV/AIDS drug development and treatment (3 papers), Neurological and metabolic disorders (2 papers) and Transgenic Plants and Applications (2 papers). Scott Harkonen collaborates with scholars based in United States. Scott Harkonen's co-authors include Carl M. Kjellstrand, R P Mischak, Patrick J. Scannon, Lynn E. S̄pitler, T. C. Merigan, John W. Torseth, Terrence F. Blaschke, Gulshan Bhatia, Michael Skinner and J B Stoudemire and has published in prestigious journals such as The American Journal of Medicine, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Scott Harkonen

11 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott Harkonen United States	10	118	100	93	91	69	11	420
Mark S. Schiffer United States	7	220 1.9×	151 1.5×	65 0.7×	63 0.7×	20 0.3×	7	502
Schwartz Rh United States	8	18 0.2×	106 1.1×	72 0.8×	91 1.0×	46 0.7×	23	429
First Mr United States	12	32 0.3×	182 1.8×	35 0.4×	56 0.6×	68 1.0×	46	569
R Shapiro United States	15	50 0.4×	153 1.5×	50 0.5×	97 1.1×	84 1.2×	34	712
Dale H. Sillix United States	12	59 0.5×	271 2.7×	38 0.4×	37 0.4×	82 1.2×	15	635
Cristóvão Luís Pitangueira Mangueira Brazil	12	40 0.3×	117 1.2×	24 0.3×	96 1.1×	112 1.6×	48	475
David Jaffe United States	7	176 1.5×	94 0.9×	94 1.0×	16 0.2×	196 2.8×	13	450
Johan Noble France	16	109 0.9×	131 1.3×	45 0.5×	129 1.4×	62 0.9×	78	641
Hideaki Oka Japan	9	43 0.4×	106 1.1×	104 1.1×	56 0.6×	62 0.9×	50	370
Jean-Pierre Venetz Switzerland	14	65 0.6×	227 2.3×	47 0.5×	140 1.5×	110 1.6×	36	704

Countries citing papers authored by Scott Harkonen

Since Specialization

Citations

This map shows the geographic impact of Scott Harkonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Harkonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Harkonen more than expected).

Fields of papers citing papers by Scott Harkonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Harkonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Harkonen. The network helps show where Scott Harkonen may publish in the future.

Co-authorship network of co-authors of Scott Harkonen

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Harkonen. A scholar is included among the top collaborators of Scott Harkonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Harkonen. Scott Harkonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Kotloff, Karen L., et al.. (1996). Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults. Vaccine. 14(5). 446–450. 22 indexed citations

Schwartz, David H., Abhijit Mazumdar, Stuart Winston, & Scott Harkonen. (1995). Utility of various commercially available human immunodeficiency virus (HIV) antibody diagnostic kits for use in conjunction with efficacy trials of HIV-1 vaccines. Clinical and Diagnostic Laboratory Immunology. 2(3). 268–271. 9 indexed citations

Anasetti, Claudio, Paul J. Martin, John A. Hansen, et al.. (1990). A PHASE I-II STUDY EVALUATING THE MURINE ANTI-IL-2 RECEPTOR ANTIBODY 2A3 FOR TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE. Transplantation. 50(1). 49–61. 44 indexed citations

Torseth, John W., Scott Harkonen, Carroll Child, et al.. (1989). Evaluation of the Antiviral Effect of Rifabutin in AIDS-Related Complex. The Journal of Infectious Diseases. 159(6). 1115–1118. 11 indexed citations

Skinner, Michael, John W. Torseth, Gulshan Bhatia, et al.. (1989). Pharmacokinetics of rifabutin. Antimicrobial Agents and Chemotherapy. 33(8). 1237–1241. 68 indexed citations

Harkonen, Scott, Patrick J. Scannon, R P Mischak, et al.. (1988). Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients. Antimicrobial Agents and Chemotherapy. 32(5). 710–716. 42 indexed citations

Harkonen, Scott, et al.. (1987). Effect of Cyclophosphamide on the Immunogenicity of Monoclonal Antimelanoma Antibody-Ricin A Chain Immunotoxin in Rats. PubMed. 4(3). 151–157. 6 indexed citations

Harkonen, Scott, et al.. (1987). Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin in rats.. PubMed. 47(5). 1377–82. 32 indexed citations

Harkonen, Scott & Carl M. Kjellstrand. (1981). Contrast Nephropathy. American Journal of Nephrology. 1(2). 69–77. 64 indexed citations

10.

Harkonen, Scott & Carl M. Kjellstrand. (1979). Intravenous Pyelography in Nonuremic Diabetic Patients. The Nephron journals/Nephron journals. 24(6). 268–270. 16 indexed citations

11.

Harkonen, Scott & Carl M. Kjellstrand. (1977). Exacerbation of diabetic renal failure following intravenous pyelography. The American Journal of Medicine. 63(6). 939–946. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact